Archive for November 15th, 2011

PATH to resubmit NDA. NGSX March PDUFA date. CADX offering. Updates for DYAX CYCC GERN PCYC

Nov 15, 2011 No Comments by

NuPathe Inc. (NASDAQ: PATH) announced that it intends to resubmit its NDA in 1H 2012 for its migraine patch that was issued a CRL in August 2011. NeurogesX, Inc. (Nasdaq:NGSX) announced that the FDA has accepted for review the its supplemental new drug application (sNDA) for Qutenza (capsaicin) 8 percent, for the management of neuropathic […]

Daily News Read more